过去一年中添加的文章，按日期排序
1031P ANV419, a selective IL-2Rβ/γ agonist in patients with relapsed/refractory advanced solid tumors
275 天前 - … ANV419-001 is an open-label, phase 1 dose escalation study of intravenous
single-… A 3+3 dose escalation design was applied. Primary objective was to evaluate the safety …
single-… A 3+3 dose escalation design was applied. Primary objective was to evaluate the safety …